# Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment

> **NCT02211560** · NA · TERMINATED · sponsor: **Enzymotec** · enrollment: 97 (actual)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **OTHER:** Phosphatidylserine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02211560
- **Lead sponsor:** Enzymotec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-09
- **Primary completion:** 2017-12-25
- **Final completion:** 2017-12-25
- **Target enrollment:** 97 (ACTUAL)
- **Why stopped:** Due to difficulties in patient recruitment
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02211560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02211560, "Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02211560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*